A Comprehensive Guide to CPT Codes for Urine Culture

In the intricate world of medical billing and laboratory science, a simple urine sample transforms into a complex narrative told through numbers, microbiology, and alphanumeric codes. For physicians, the story is one of diagnosis and treatment—identifying the pathogen causing a patient’s dysuria or confirming a sterile field before urologic surgery. For microbiologists, it’s a tale of colony counts, Gram stains, and biochemical reactions. But for medical coders, billers, and practice managers, this story is translated into the universal language of healthcare reimbursement: Current Procedural Terminology (CPT®) codes.

A misunderstanding or misapplication of a single code, such as 87086 or 87088, can be the difference between a clean claim and a denied one, between appropriate reimbursement and a costly write-off. It can even trigger audits and compliance reviews. The process of coding a urine culture is deceptively nuanced. It is not merely about choosing a code from a list; it’s about understanding the clinical question being asked, the laboratory procedures performed, and the precise definitions enshrined in the CPT® manual by the American Medical Association (AMA).

This comprehensive guide is designed to be the definitive resource for this critical topic. We will move beyond basic definitions into a detailed exploration of the urine culture CPT codes, the clinical scenarios they represent, the documentation required to support them, and the compliance landscape that governs their use. Whether you are a seasoned medical coder, a new lab technician, a healthcare administrator, or a curious clinician, this article will provide the depth of knowledge necessary to navigate this essential aspect of diagnostic medicine with confidence and accuracy.

2. The Clinical Foundation: Why We Culture Urine

Before a single code can be assigned, one must understand the “why” behind the test. Urine culture is a diagnostic microbiology procedure used to detect and identify microorganisms (primarily bacteria and yeast) in a patient’s urine. It is a cornerstone in the diagnosis of:

• Urinary Tract Infections (UTIs): One of the most common bacterial infections, affecting millions annually. Symptoms can include painful urination (dysuria), frequent urination (frequency), urgency, suprapubic pain, and cloudy or foul-smelling urine.

• Pyelonephritis: A more serious infection that has ascended from the bladder to the kidneys, often accompanied by fever, chills, and flank pain.

• Asymptomatic Bacteriuria: The presence of significant bacteria in the urine without symptoms. Screening for this is often performed in pregnant women or prior to certain invasive urologic procedures to prevent complications.

• Follow-up Testing: To confirm the effectiveness of antibiotic treatment after a course of therapy for a UTI.

The culture process itself is designed to not only detect the presence of organisms but also to quantify them (how many are present) and qualify them (what specific type they are). This is crucial because urine is not sterile, and low levels of bacteria can be present due to contamination from the skin or genital flora during collection. The classic threshold for defining a “true” UTI, rather than contamination, is the presence of ≥ 10⁵ colony-forming units per milliliter (CFU/mL) of a uropathogen. However, in symptomatic women, a lower count of ≥ 10² CFU/mL of a classic uropathogen like E. coli may be considered significant.

3. Navigating the CPT® Code Set: An Overview

The CPT® code set, published and maintained by the AMA, is a uniform coding system used to describe medical, surgical, and diagnostic services. It is the standard for reporting services to Medicare, Medicaid, and private payers in the United States. The codes for urine culture fall under the Pathology and Laboratory section, specifically within the Microbiology subsection (87001-87999).

These codes are largely procedural, meaning they describe the technical work performed by the laboratory. It is vital to remember that CPT codes represent distinct procedures. Ordering multiple codes for what is essentially a single integrated process is often incorrect and can be considered “unbundling,” a compliance violation.

4. Deep Dive: The Core Urine Culture Codes

This is the heart of the coding process. Understanding the subtle but critical differences between these codes is paramount.

CPT 87086: Culture, bacterial; quantitative, urine

• What it is: This is the workhorse code for a standard quantitative urine culture. It describes the process of inoculating a measured volume of urine onto culture media (e.g., blood agar, MacConkey agar), incubating it, and then counting the number of bacterial colonies that grow. The result is reported quantitatively (e.g., “>100,000 CFU/mL of Escherichia coli” or “No growth at 24/48 hours”).

• What it includes: The code includes the plating, incubation, and colony count. It implies that if growth is present, a presumptive identification has been made based on colonial morphology (how the colony looks) and Gram stain characteristics. For example, a lactose-fermenting gram-negative rod on MacConkey agar is presumptively identified as a member of the Enterobacteriaceae family (e.g., E. coli, Klebsiella).

• When to use it: This is the appropriate code when a full quantitative culture is performed, regardless of whether the result is positive, negative, or shows mixed flora. It is used for both diagnostic and screening purposes.

CPT 87087: Concentration, any type (The Misunderstood Code)

• What it is: This is a specimen preparation code, not a culture code. It describes a procedure to concentrate the sediment from a liquid specimen (like urine or body fluids) through centrifugation. The concentrated sediment is then used for further testing, most commonly for a microscopic examination (e.g., urinalysis microscopic, 81015).

• Common Misapplication: Coders sometimes mistakenly report 87087 alongside 87086 for a routine urine culture. This is incorrect.

• CPT Manual Guidance: The CPT manual parenthetical note following code 87087 explicitly states: (For concentration and particle counting in urinalysis, see 81015, 81020). Furthermore, it states: (Do not report 87087 in addition to 81015, 81020 for the same specimen).

• When to use it (Correctly): This code is rarely used for routine urine. It is appropriately used for concentrating other body fluids (e.g., cerebrospinal fluid, pleural fluid) for microbiological smear and culture when that concentration step is a separate, distinct procedure not included in the culture code itself.

CPT 87088: Culture, bacterial; with isolation and presumptive identification of each isolate, urine

• What it is: This code represents a higher level of service than 87086. It is used when the laboratory must perform additional work to isolate and identify multiple organisms from a single urine specimen. The key phrase is “each isolate.”

• When to use it: Report 87088 instead of 87086 when the urine culture reveals mixed flora (typically three or more organisms) and the lab must work to isolate each different type of bacterium into a pure culture and then perform presumptive identification on each one. This is common in specimens that are likely contaminated or from patients with complex medical histories (e.g., long-term catheterization).

• Example: A urine culture grows >100,000 CFU/mL of three different organisms: a gram-positive coccus, a lactose-fermenting gram-negative rod, and a non-lactose-fermenting gram-negative rod. The technologist must subculture each organism to isolate it and then perform tests (like catalase, coagulase, oxidase, or indole) to presumptively identify each one (e.g., Staphylococcus epidermidis, E. coli, and Pseudomonas aeruginosa). This extra work justifies the use of 87088.

• Crucial Note: You never report both 87086 and 87088 for the same specimen. Code 87088 is a complete service that includes the quantitative culture and the additional isolation/identification work.

CPT 87184: Culture, presumptive, pathogenic organisms, screening only;

• What it is: This code describes a screening test, not a definitive diagnostic culture. It uses simplified, often automated or chromogenic, media designed to quickly detect common uropathogens. These are frequently used in outpatient settings, urgent care clinics, or as a high-volume screening tool.

• Key Differentiator: The code descriptor includes “screening only.” These tests are designed for speed and efficiency to rule out infection. They lack the full quantitative aspect and detailed identification of 87086/87088. If a screening test is positive, it is common practice to reflex to a full quantitative culture (87086) for confirmation and identification.

• When to use it: Use this code only when a rapid, presumptive screening test is performed and no further culture work is done. If the screen is positive and is followed up with a standard culture, you typically only report the definitive culture code (87086), as the screening is considered a bundled component of the diagnostic process. Always follow payer-specific guidelines on this matter.

Table 1: Comparison of Primary Urine Culture CPT Codes

5. The Critical Role of Specimen Collection: Method Matters

The accuracy of a urine culture result is profoundly affected by how the specimen is collected. The method of collection is also a critical data point for the microbiologist interpreting the results and the coder ensuring accuracy.

• Clean-Catch Midstream (CCMS): The gold standard for non-invasive collection. The patient cleans the urethral area and collects urine mid-stream to minimize contamination from skin flora. This is the most common method.

• Catheterized Specimen: Collected via a urinary catheter, either in-dwelling or straight catheterization. This method bypasses the urethra, offering a lower risk of contamination. The presence of an in-dwelling catheter, however, is a risk factor for infection itself.

• Suprapubic Aspiration: A needle is inserted through the abdominal wall directly into the bladder. This is the most invasive method but provides a specimen completely free of urethral contamination. It is considered the definitive method, especially in pediatric patients or complex cases.

• Ileal Conduit / Urostomy: Collection from a surgically created diversion.

Why it matters for coding: While the collection method itself does not change the culture code (87086/87088), it is essential for correct coding of the specimen collection code. For example, catheterization is reported with CPT code 51701 (Insertion of non-indwelling bladder catheter) or 51702 (if performed by a nurse). Collection of a clean-catch void is typically considered part of the E/M service and not separately billable.

6. Beyond Culture: The Complete Urinalysis Profile (81000-81020)

A urine culture is often ordered alongside or as a follow-up to a urinalysis (UA). The UA is a group of screening tests that can suggest infection. It is vital to understand these codes to avoid incorrect billing.

• CPT 81001: Urinalysis, automated, with microscopy.

• CPT 81002: Urinalysis, automated, without microscopy.

• CPT 81003: Urinalysis, dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy.

• CPT 81005: …without microscopy.

• CPT 81015: Urinalysis; microscopic only.

• CPT 81020: Urinalysis; two or three glass test

The presence of leukocyte esterase (a marker for white blood cells) and nitrite (a byproduct of some bacteria) on a dipstick UA is a common indicator that a UTI may be present, prompting the physician to order a culture. Crucially, a urinalysis is included in a global surgical package and is not separately billable if performed on a specimen obtained during a catheterization procedure (51701/51702).

7. The Algorithm of Coding: A Step-by-Step Guide

Follow this logical decision tree to arrive at the correct code(s):

1. Review the Test Order: What did the clinician order? “UA and culture,” “C&S,” “Urine culture only”?

2. Review the Lab Report: This is the most important document.

   • Does the report show a quantitative result (e.g., CFU/mL)? → This points to 87086 or 87088.

   • How many organisms were identified?

     • One or two organisms: → Report 87086.

     • Three or more organisms that the lab had to isolate and presumptively identify: → Report 87088.

   • Does the report describe a rapid, automated, or screening test without a quantitative count? → This may be 87184, but confirm if it reflexed to a culture.

3. Check for Additional Procedures: Was a Gram stain performed? If it was performed on the urine sediment, it may be separately reportable with 87210 (Smear, primary source with interpretation; Gram or Giemsa stain). However, if the Gram stain is performed on the bacterial growth from the culture plate (which is common), it is considered part of the identification process and bundled into 87086/87088.

4. Verify Medical Necessity: Ensure the diagnosis code (ICD-10-CM) on the claim supports the medical necessity of the culture. Examples: N39.0 (UTI, site not specified), R30.0 (Dysuria), O23.40 (Infection of urinary tract in pregnancy, unspecified).

8. Documentation is King: What the Lab Needs from the Clinician

Accurate coding is impossible without accurate documentation. The clinician’s order and the patient’s medical record must provide:

• Test Ordered: Clearly state “urine culture.”

• Clinical Indication/Symptoms: The reason for the test (e.g., dysuria, frequency, fever, flank pain, screening). This provides the medical necessity.

• Specimen Source and Collection Method: “Urine, CCMS,” “Urine, catheter,” etc.

• Relevant Patient History: “Pregnancy,” “history of recurrent UTIs,” “indwelling catheter,” “pre-op for cystoscopy.”

The laboratory report must clearly document:

• Quantitative Result: The CFU/mL for each organism.

• Identification: The genus and, if possible, species of each organism identified (e.g., Escherichia coli, Proteus mirabilis, Group B Streptococcus).

• Antimicrobial Susceptibility Testing (if performed): This is reported with separate codes from the 8718x series (e.g., 87184 is for screening culture, 87186 is for susceptibility testing).

9. Navigating Payer Policies: Medicare, Medicaid, and Commercial Insurers

Payers often have specific Local Coverage Determinations (LCDs) or policies that further define how they will reimburse these codes.

• Medicare (NCCI Edits): The National Correct Coding Initiative (NCCI) edits are rules that prevent improper billing when certain codes are reported together. For example, NCCI edits bundle the screening culture code (87184) into the definitive culture code (87086). You cannot bill both for the same patient on the same day. Always check the NCCI edits before submitting a claim.

• Frequency Edits: Payers may have limits on how often a urine culture is considered medically necessary for a patient with chronic conditions without a change in symptoms.

• Medical Necessity: The number one reason for denial is lack of medical necessity. Coding with a diagnosis of Z00.00 (general adult medical exam) will almost certainly lead to a denial for a screening culture in an asymptomatic adult. The ICD-10 code must match the clinical scenario.

10. Compliance and Auditing: Avoiding Costly Errors

Incorrect coding for urine cultures is a common audit target. Key areas of risk include:

• Unbundling: Reporting 87086 and 87088 together.

• Misuse of 87087: Illegitimately adding the concentration code to a routine urine culture claim.

• Lack of Medical Necessity: Performing and billing for screening tests that do not meet payer criteria (e.g., routine pre-op screening on all patients).

• Overutilization: Billing for cultures at a frequency that is not supported by the patient’s condition.

A strong compliance program involves regular internal audits of laboratory billing practices to identify and correct these errors before they are found by an external auditor.

11. The Future of Urine Testing: Molecular Diagnostics and PCR Codes

The field is evolving with the adoption of multiplex molecular assays that can detect the DNA of numerous pathogens directly from a urine sample in a matter of hours, not days. These tests use codes from the 87471-87899 series (Infectious Agent Detection by Nucleic Acid).

• Example: 87481 (Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group B, amplified probe technique) might be used on a urine sample from a pregnant patient.

• Panels: Larger panels (e.g., 87647 for gastrointestinal pathogens) are becoming more common. It is critical to understand that these molecular tests are distinct from culture. They detect genetic material, not live organisms, and cannot provide a quantitative count or antibiotic susceptibility information. However, they are extremely sensitive and fast.

• Coding Guidance: If a molecular test is performed, you would report the appropriate molecular code. If a reflex culture is then performed for susceptibility testing, you may report both the molecular code and the culture code (87086), as they are fundamentally different methodologies. Always append modifier -59 (Distinct Procedural Service) if required by NCCI edits to indicate the tests were separate and distinct.

12. Conclusion: Synthesizing Knowledge for Accurate Reimbursement

Accurately coding for urine cultures requires a synthesis of clinical knowledge, procedural understanding, and regulatory awareness. The difference between 87086 and 87088 hinges on the laboratory’s work to isolate multiple organisms, not simply the number reported. Always consult the most current CPT manual and payer-specific policies, as guidelines can and do change. Robust documentation from both the clinician and the laboratory is the non-negotiable foundation that supports correct coding, ensures patient safety, and secures appropriate reimbursement while maintaining compliance.

13. Frequently Asked Questions (FAQs)

Q1: Can I bill CPT 87086 and 87088 together for the same urine specimen?
A: Absolutely not. Code 87088 is a complete service that includes all the work described by 87086 plus the additional isolation and identification of multiple organisms. Reporting both codes together is considered unbundling and is a compliance violation.

Q2: A urine culture showed “>100,000 CFU/mL of mixed genital flora.” What code should I use?
A: This is a scenario for 87086. The result “mixed genital flora” typically implies contamination, and the laboratory did not perform the additional work to isolate and identify each organism in the mixture. They simply reported the quantitative result of the mixed culture. Code 87088 is only used if the lab’s report details the isolation and presumptive identification of three or more specific organisms.

Q3: Our lab uses an automated system for initial screening. If it’s positive, we do a full culture. What codes do we bill?
A: In nearly all cases, you only bill for the definitive test—the full quantitative culture (87086). The automated screening is considered a procedural component leading to the definitive result and is not separately reportable. Check specific payer policies, but the standard practice is to bill only 87086.

Q4: The doctor ordered “UA and C&S.” What does that mean for coding?
A: “C&S” stands for “Culture and Sensitivity.” This means the lab should perform a quantitative urine culture (87086 or 87088). If organisms are isolated, they will perform antimicrobial susceptibility testing (AST), which is billed with a separate code, typically 87186 (Susceptibility studies, antimicrobial, microdilution or agar dilution, each multi-antimicrobial panel). You would report both the culture code and 87186 (for each panel of antibiotics tested) if both procedures are performed.

Q5: Is a urine culture ever bundled into a surgical procedure?
A: Yes. If a urine culture is performed on a specimen collected during a surgical procedure or a related E/M service on the same day, it may be considered part of the global package and not separately billable. This is complex, and you must consult the CPT manual’s global surgery rules and payer policies.

14. Additional Resources

• The American Medical Association (AMA): The definitive source for the CPT® code set. Access to the full manual and digital tools is essential.

  • https://www.ama-assn.org/

• Centers for Medicare & Medicaid Services (CMS): Provides access to NCCI edits, Medicare coverage policies (LCDs), and transmittals.

  • https://www.cms.gov/

  • NCCI Policy Manual

• Clinical Laboratory Improvement Amendments (CLIA): Federal regulations for all laboratory testing.

  • https://www.cms.gov/regulations-and-guidance/legislation/clia

• American Society for Clinical Pathology (ASCP): Offers resources, continuing education, and guidance for laboratory professionals.

  • https://www.ascp.org/

• American Academy of Professional Coders (AAPC): A leading organization for medical coders, offering certifications, training, and local chapters.

  • https://www.aapc.com/